Immunomedics Inc. 

NJ

  SEC # 722830

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  7/6/83   —   First EDGAR Filing:  5/12/95   –   Last Filing:  2/16/21  (None in the Past Year) 

Possible Termination of Registration and/or Duty to File Reports per 11/2/20 Form 15

Business Address      On:  2/16/21       [ Map ]		Mailing Address      On:  2/16/21       [ Map ]
300 American Rd Morris Plains, New Jersey  07950 U.S.A.		300 American Road Morris Plains, New Jersey  07950 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 973-605-8200		Delaware, U.S.A.		12/31/yy		61-1009366		0000722830		000-12104

Industry Classification
SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2835 In Vitro and In Vivo Diagnostic Substances 2021 SEC Office of Life Sciences

        

Management
Director   In   NY   Aghazadeh Behzad 2017-2020   NY   Avoro Capital Advisors LLC 2017-2020   MA   Canute Scott A 2017-2020   DC   Hutt Peter Barton 2017-2020   NJ   Islam Khalid 2017-2020   CA   Baum Charles M 2019-2020   NY   Duncan Barbara Gayle 2019-2020   WA   Azelby Robert 2020   NJ   Semerjian Harout 2020   NY   Goldenberg David M 2003-2018   NJ   Goldenberg Cynthia L 2004-2017   TN   Markison Brian A 2004-2017   MA   Stark Don C 2005-2017   CA   Aryeh Jason 2017   MA   Cox Geoffrey F 2017   MA   Forrester Robert 2017   NJ   Oliver Bob 2017   NJ   Pehl Michael F. 2017   NJ   Paetzold Mary E 2003-2016 ↓List Pre-2016 Directors				Officer  Since  Most-Recent Title   In   NJ   Itri Lorettta M Chief Medical Officer 2020   NJ   Semerjian Harout President & CEO 2020   NJ   Ball Bryan 2019 Chief Quality Officer 2020   NJ   Andrews Kurt J. 2018 Chief Human Resources Officer 2020   NJ   Freedberg Jared 2018 Gen. Counsel & Corp. Secretary 2020   NJ   Fricker William 2018 Principal Accounting Officer 2020   NJ   Malik Usama 2018 Chief Fin. & Business Officer 2020   NJ   Delaney Brendan 2017 Chief Commercial Officer 2020   NJ   Iannone Robert 2018 Chief Medical Officer 2019   WA   Rosenberg Morris 2018 Chief Technology Officer 2019   NJ   Pehl Michael F. 2017 President & CEO 2018   NJ   Garone Michael 2016 Chief Financial Officer 2017   NY   Goldenberg David M 2004 See Remarks 2017   NJ   Goldenberg Cynthia L 2003 President & CEO 2016 ↓List Pre-2016 Officers

        

        

        

        

Securities
CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2023:   452907 452907·10·8     Common 452907·01·7     Options 452907·AJ·7     Convertible Bonds 452907·AK·4     Notes 4.750% 2/1 _________  Classes source:  Form 13F Filings that list Section 13(f) Securities